BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22283979)

  • 21. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
    Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
    Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
    Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-derived infections among Chinese donation after cardiac death liver recipients.
    Ye QF; Zhou W; Wan QQ
    World J Gastroenterol; 2017 Aug; 23(31):5809-5816. PubMed ID: 28883707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ utilization among deceased donors in Canada, 1993-2002.
    Badovinac K; Greig PD; Ross H; Doig CJ; Shemie SD
    Can J Anaesth; 2006 Aug; 53(8):838-44. PubMed ID: 16873352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor.
    Detry O; De Roover A; de Leval L; Herens C; Delwaide J; Honoré P; Meurisse M
    Liver Transpl; 2005 Jun; 11(6):696-9. PubMed ID: 15915495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients.
    Blodget E; Geiseler PJ; Larsen RA; Stapfer M; Qazi Y; Petrovic LM
    Transpl Infect Dis; 2012 Jun; 14(3):305-10. PubMed ID: 22176511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttransplant bacteremia in adult living donor liver transplant recipients.
    Iida T; Kaido T; Yagi S; Yoshizawa A; Hata K; Mizumoto M; Mori A; Ogura Y; Oike F; Uemoto S
    Liver Transpl; 2010 Dec; 16(12):1379-85. PubMed ID: 21117247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.
    Tacconelli E; Tumbarello M; Bertagnolio S; Citton R; Spanu T; Fadda G; Cauda R
    Emerg Infect Dis; 2002 Feb; 8(2):220-1. PubMed ID: 11897080
    [No Abstract]   [Full Text] [Related]  

  • 30. Transmission of Trypanosoma cruzi by heart transplantation.
    Kun H; Moore A; Mascola L; Steurer F; Lawrence G; Kubak B; Radhakrishna S; Leiby D; Herron R; Mone T; Hunter R; Kuehnert M;
    Clin Infect Dis; 2009 Jun; 48(11):1534-40. PubMed ID: 19400748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
    Harper AM; Rosendale JD
    Clin Transpl; 1996; ():69-90. PubMed ID: 9286559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa endocarditis in renal transplant recipients.
    Nasim A; Baqi S; Akhtar SF
    Transpl Infect Dis; 2012 Apr; 14(2):180-3. PubMed ID: 21883760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of other organs recovered during in situ split-liver procurements.
    Ramcharan T; Glessing B; Lake JR; Payne WD; Humar A
    Liver Transpl; 2001 Oct; 7(10):853-7. PubMed ID: 11679982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
    Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation.
    Mattner F; Kola A; Fischer S; Becker T; Haverich A; Simon A; Suerbaum S; Gastmeier P; Weissbrodt H; StrĂ¼ber M
    Infection; 2008 Jun; 36(3):207-12. PubMed ID: 18470477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actual and potential supply of organ donors in the United States.
    Evans RW
    Clin Transpl; 1990; ():329-41. PubMed ID: 2103157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving cadaveric organ donation rates in kidney and liver transplantation in Asia.
    Vathsala A
    Transplant Proc; 2004 Sep; 36(7):1873-5. PubMed ID: 15518680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Strategies for a greater supply of organs for transplantation].
    Gridelli B; Perico N; Remuzzi G
    Recenti Prog Med; 2001 Jan; 92(1):9-15. PubMed ID: 11260978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.
    Qiao B; Wu J; Wan Q; Zhang S; Ye Q
    BMC Infect Dis; 2017 Feb; 17(1):171. PubMed ID: 28241746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.